Department of Urology, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany.
Anticancer Res. 2010 Jul;30(7):2785-9.
To analyse the diagnostic and prognostic value of cell-free DNA in patients with renal cell carcinoma (RCC).
Cell-free DNA was measured in 35 patients with RCC and 54 healthy individuals using quantitative real-time PCR. ACTB-106 detects fragmented cell-free DNA due to apoptosis and ACTB-384 detects long DNA fragments by necrosis. DNA-Integrity (ACTB-384/ACTB-106 ratio) served as measure of DNA fragmentation.
Levels of both DNA fragments were increased in RCC patients compared to healthy individuals (ACTB-384: 1.77 vs. 0.61ng/ml, p=0.0003; ACTB-106: 1.31ng/ml vs. 0.77 ng/ml p=0.003). Receiver operator characteristic analysis (ROC) showed at a threshold level of 1.03 ng/ml for ACTB-106 68.6%, sensitivity and 70.4% specificity (AUC: 0.69). ROC analysis showed at a threshold level of 1.70 ng/ml for ACTB-384 57.1%, sensitivity and 81.5% specificity (AUC: 0.73). DNA integrity was increased in RCC (1.07 vs. 0.72 p=0.04). In vascular invasion the DNA integrity was reduced (p=0.003).
Cell-free-DNA levels are increased in RCC. The DNA integrity indicates mostly necrotic origin in RCC.
分析游离 DNA 在肾细胞癌 (RCC) 患者中的诊断和预后价值。
使用实时定量 PCR 法检测 35 例 RCC 患者和 54 例健康个体的游离 DNA。ACTB-106 检测凋亡导致的游离 DNA 片段化,ACTB-384 检测坏死引起的长 DNA 片段。DNA 完整性(ACTB-384/ACTB-106 比值)作为 DNA 片段化的衡量指标。
与健康个体相比,RCC 患者的两种 DNA 片段水平均升高(ACTB-384:1.77 比 0.61ng/ml,p=0.0003;ACTB-106:1.31ng/ml 比 0.77ng/ml,p=0.003)。接受者操作特征分析(ROC)显示,ACTB-106 的截断值为 1.03ng/ml 时,敏感性为 68.6%,特异性为 70.4%(AUC:0.69)。ROC 分析显示,ACTB-384 的截断值为 1.70ng/ml 时,敏感性为 57.1%,特异性为 81.5%(AUC:0.73)。RCC 中 DNA 完整性增加(1.07 比 0.72,p=0.04)。血管侵犯时 DNA 完整性降低(p=0.003)。
RCC 患者的游离 DNA 水平升高。DNA 完整性主要表明 RCC 为坏死来源。